New system offers a standardized and simplified alternative to traditional handwritten line labeling that supports safer medication administration Solution aims to streamline nursing workflow, helping ...
Baxter International Inc. BAX is scheduled to release fourth-quarter 2025 results on Feb. 12, before the opening bell. In the last reported quarter, the company’s earnings beat the Zacks Consensus ...
Baxter International Inc. (NYSE:BAX) is one of the top cheap stocks under $20 to buy now. On December 12, Wells Fargo analyst Larry Biegelsen reiterated a Hold rating on Baxter International Inc.
DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The University of Texas ...
Data shared in collaboration with The University of Texas Medical Branch, representing an analysis of more than one million intravenous (IV) infusions using Baxter’s Spectrum IQ large volume infusion ...
Baxter’s efforts this summer to correct high-risk issues with its infusion pumps has gotten more complicated. Last month, the company and the FDA alerted the public to a problem with the large-volume ...
IRVING, Texas--(BUSINESS WIRE)--Vizient ® announced today the expansion of the Vizient Reserve Program to include IV fluids through a strategic partnership with Baxter, a leading global medtech ...
Following long-time chief José Almeida’s retirement earlier this year, Baxter announced it has officially named a new CEO. Andrew Hider will join the medtech after about eight years of leading ATS, a ...
Baxter International, a prominent healthcare and pharmaceutical manufacturer, reports that President Trump's tariffs will likely cost the company $60 million to $70 million this year. Baxter makes a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results